Evidence map›Paper›PMID 11086024›Full record

ArticleThe Journal of clinical investigation2000

Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha.

S Cenci, M N Weitzmann, C Roggia, N Namba, D Novack, J Woodring, R Pacifici

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 291 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
291citing papers in PubMed, 2 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

291 citing papers in PubMed, 2 syntheses or guidelines pooled it, 687 citations in OpenAlex.

  1. The role of CD8Frontiers in immunology · 2026
    Pooled it
  2. Pooled it
  3. Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2013
    Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

231 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

S CenciDivision of Bone and Mineral Diseases, Washington University School of Medicine and Barnes-Jewish Hospital, St. Louis, Missouri 63110, USA.
M N Weitzmann
C Roggia
N Namba
D Novack
J Woodring
R Pacifici
Barnes-Jewish Hospital · USIRCCS Ospedale San Raffaele · IT

Funding

IL-1 RECEPTOR ANTA IN OVARRIECTOMY INDUCED BONE LOSSR01AR041412 · NIAMS · JEWISH HOSPITAL OF SAINT LOUIS · PI PACIFICI, ROBERTO · 1991 to 2004
$1.4M
NIAMS NIH HHS AR-13534NIAMS NIH HHS AR-41412NIAMS NIH HHS R01 AR041412
6 · The paper itself

Abstract

Estrogen deficiency induces bone loss by upregulating osteoclastogenesis by mechanisms not completely defined. We found that ovariectomy-enhanced T-cell production of TNF-alpha, which, acting through the TNF-alpha receptor p55, augments macrophage colony-stimulating factor-induced (M-CSF-induced) and RANKL-induced osteoclastogenesis. Ovariectomy failed to induce bone loss, stimulate bone resorption, or increase M-CSF- and RANKL-dependent osteoclastogenesis in T-cell deficient mice, establishing T cells as essential mediators of the bone-wasting effects of estrogen deficiency in vivo. These findings demonstrate that the ability of estrogen to target T cells, suppressing their production of TNF-alpha, is a key mechanism by which estrogen prevents osteoclastic bone resorption and bone loss.

Indexed as

AnimalsAntigens, CDBone ResorptionCarrier ProteinsCells, CulturedEstrogensMacrophage Colony-Stimulating FactorMembrane GlycoproteinsMiceMice, Inbred C57BLMice, KnockoutMice, NudeOsteoclastsOvariectomyRANK LigandReceptor Activator of Nuclear Factor-kappa BAntigens, CDCarrier ProteinsEstrogensMacrophage Colony-Stimulating FactorMembrane GlycoproteinsRANK LigandReceptor Activator of Nuclear Factor-kappa BReceptors, Tumor Necrosis FactorReceptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IITnfrsf11a protein, mouseTnfsf11 protein, mouseTumor Necrosis Factor-alpha

Identifiers

PMID11086024
PMCPMC381439
OpenAlexW2133281510

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.